Thymosin Alpha-1 in 2026: Zadaxin Trial Data, Sepsis & Cancer Immunotherapy Research, and TB-500 Comparison

What the published trials actually show about thymosin alpha-1 (Zadaxin): hepatitis B, sepsis, cancer-immunotherapy adjunct studies, 2026 regulatory status, and how it differs from TB-500.